HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Takahiro Kawamoto Selected Research
Takahiro Kawamoto Research Topics
Disease
3
Fibrosis (Cirrhosis)
02/2013 - 05/2007
3
Atherosclerotic Plaque (Atheroma)
10/2010 - 10/2007
2
Myocardial Ischemia (Ischemic Heart Diseases)
10/2010 - 09/2009
2
Atrial Fibrillation
08/2010 - 07/2010
2
Angina Pectoris
08/2010 - 06/2009
2
Heart Valve Diseases (Valvular Heart Disease)
07/2010 - 02/2004
2
Hypertension (High Blood Pressure)
07/2010 - 01/2009
2
Atherosclerosis
06/2009 - 10/2008
2
Left Ventricular Dysfunction
01/2008 - 08/2005
1
AIDS-Related Complex (ARC)
01/2014
1
Obstructive Sleep Apnea
06/2011
1
Pathologic Constriction (Stenosis)
09/2010
1
Stroke (Strokes)
08/2010
1
Heart Failure
08/2010
1
Heart Diseases (Heart Disease)
07/2010
1
Inflammation (Inflammations)
07/2010
1
Thrombosis (Thrombus)
07/2010
1
Cardiovascular Diseases (Cardiovascular Disease)
06/2009
1
Aortic Valve Stenosis (Aortic Stenosis)
10/2008
1
Coronary Stenosis (Coronary Artery Stenosis)
10/2007
1
Calcinosis
05/2007
1
Cicatrix (Scar)
05/2007
1
Leukemia
11/2005
1
Neointima
11/2005
1
Hyperemia
01/2005
1
Endocarditis
02/2004
Drug/Important Bio-Agent (IBA)
4
C-Reactive Protein
IBA
08/2010 - 10/2008
3
Lipids
IBA
02/2013 - 10/2010
1
Calcium
IBA
01/2014
1
Fluspirilene (Imap)
IBA
02/2013
1
Ticlopidine (Ticlid)
FDA Link
Generic
07/2010
1
Edaravone
IBA
09/2009
1
Bosentan (Tracleer)
FDA Link
01/2009
1
Catecholamines
IBA
01/2008
1
Oxygen (Dioxygen)
IBA
10/2007
1
trichrome stain
IBA
05/2007
1
Cholesterol
IBA
05/2007
1
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
05/2007
1
DDT
IBA
08/2005
1
Adenosine Triphosphate (ATP)
IBA
01/2005
1
Integrin alpha4beta1 (VLA-4)
IBA
02/2004
1
Chemokine CXCL16
IBA
02/2004
Therapy/Procedure
4
Percutaneous Coronary Intervention
10/2010 - 06/2009
2
Stents
01/2014 - 11/2005
2
Therapeutics
06/2011 - 10/2007
1
Continuous Positive Airway Pressure
06/2011
1
Aftercare (After-Treatment)
01/2005